Supernus Pharmaceuticals (SUPN) Current Taxes (2016 - 2020)

Supernus Pharmaceuticals (SUPN) has 5 years of Current Taxes data on file, last reported at $9.1 million in Q1 2020.

• On a quarterly basis, Current Taxes fell 47.21% year-over-year to $9.1 million in Q1 2020; TTM through Mar 2020 was $9.1 million, a 47.21% decrease from a year earlier, with the FY2019 full-year figure at $2.4 million, down 80.26% from the prior year.
• Current Taxes for Q1 2020 stood at $9.1 million, up from $2.4 million in the prior quarter.
• Over the last five years, Current Taxes for SUPN reached as high as $17.2 million in Q1 2019 and fell as low as $7000.0 in Q4 2016.
• Historically, Current Taxes has averaged $7.6 million across 5 years, with a median of $6.5 million in 2017.
• Across the five-year window, Current Taxes jumped 227585.71% in 2017 and sank 80.26% in 2019, its largest moves.
• Year by year, Current Taxes stood at $7000.0 in 2016, then soared by 227585.71% to $15.9 million in 2017, then slipped by 22.34% to $12.4 million in 2018, then sank by 80.26% to $2.4 million in 2019, then surged by 272.37% to $9.1 million in 2020.
• Per Business Quant data, the three most recent Current Taxes figures were $9.1 million in Q1 2020, $2.4 million in Q4 2019, and $4.8 million in Q3 2019.